BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10388430)

  • 1. Stage grouping of oropharyngeal cancer: evaluation of three systems by means of survival analysis.
    Carinci F; Farina A; Pelucchi S; Brunelli G; Pastore A; Calearo C
    J Craniofac Surg; 1999 Jan; 10(1):73-8. PubMed ID: 10388430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the new TNM (1997) the best system for predicting prognosis?
    Carinci F; Farina A; Longhini L; Urso RG; Pelucchi S; Calearo C
    Int J Oral Maxillofac Surg; 1999 Jun; 28(3):203-5. PubMed ID: 10355943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between TNM and TANIS stage grouping for predicting prognosis of oral and oropharyngeal cancer.
    Carinci F; Pelucchi S; Farina A; Calearo C
    J Oral Maxillofac Surg; 1998 Jul; 56(7):832-6; discussion 836-7. PubMed ID: 9663573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between TANIS and UICC 1997 stage grouping in parotid gland carcinoma.
    Carinci F; Farina A; Pelucchi S; Calearo C; Pastore A
    J Craniofac Surg; 2001 Mar; 12(2):141-4. PubMed ID: 11314624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of different TNM-based stage groupings for oral squamous cell carcinoma.
    Kreppel M; Drebber U; Rothamel D; Eich HT; Kübler A; Scheer M; Zöller JE
    Head Neck; 2011 Oct; 33(10):1467-75. PubMed ID: 21928419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension as a prognostic factor in oropharyngeal cancer: largest mucosal dimension compared with number of (sub)sites involved.
    Carinci F; Pelucchi S; Farina A; De Franciscis G; Calearo C
    Br J Oral Maxillofac Surg; 1998 Dec; 36(6):440-5. PubMed ID: 9881786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNM-based stage groupings in head and neck cancer: application in cancer of the hypopharynx.
    Hall SF; Groome PA; Irish J; O'Sullivan B
    Head Neck; 2009 Jan; 31(1):1-8. PubMed ID: 19031408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of nasopharyngeal carcinoma: evaluation of N-staging by Ho and UICC/AJCC systems. Union Internationale Contre le Cancer. American Joint Committee for Cancer.
    Lee AW; Foo W; Poon YF; Law CK; Chan DK; O SK; Tung SY; Ho JH
    Clin Oncol (R Coll Radiol); 1996; 8(3):146-54. PubMed ID: 8814368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic quality of the Union Internationale Contre le Cancer/American Joint Committee on Cancer TNM classification, 7th edition, for cancer of the maxillary sinus.
    Kreppel M; Amir Manawi NN; Scheer M; Nickenig HJ; Rothamel D; Dreiseidler T; Drebber U; Zinser M; Zöller JE; Guntinas-Lichius O; Preuss SF
    Head Neck; 2015 Mar; 37(3):400-6. PubMed ID: 24431114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
    Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical staging of oropharyngeal carcinoma: a critical evaluation of a new stage grouping proposal.
    Ambrosch P; Kron M; Freudenberg LS
    Cancer; 1998 May; 82(9):1613-20. PubMed ID: 9576278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer.
    Jones GW; Browman G; Goodyear M; Marcellus D; Hodson DI
    Head Neck; 1993; 15(6):497-503. PubMed ID: 8253556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an appropriate staging system for esophageal carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage grouping reliability: TNM '97 versus TANIS in laryngeal cancer.
    Carinci F; Farina A; Pelucchi S; Pastore A; Longhini L; Urso RG; Calearo C
    Otolaryngol Head Neck Surg; 1999 Apr; 120(4):499-501. PubMed ID: 10187941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The Netherlands.
    Hart AA; Mak-Kregar S; Hilgers FJ; Levendag PC; Manni JJ; Spoelstra HA; Bruaset IA; van der Laan BF; Annyas AA; van der Beek JM
    Cancer; 1995 Jun; 75(11):2656-62. PubMed ID: 7743466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-specific survival for a new t-stage of oropharyngeal cancer.
    Carinci F; Farina A; Bovicelli A; Pelucchi S; Calearo C
    Br J Oral Maxillofac Surg; 2000 Aug; 38(4):402-4. PubMed ID: 10922176
    [No Abstract]   [Full Text] [Related]  

  • 20. [The ASA-score as a comorbidity index in patients with cancer of the oral cavity and oropharynx].
    Riechelmann H; Neagos A; Netzer-Yilmaz U; Gronau S; Scheithauer M; Rockemann MG
    Laryngorhinootologie; 2006 Feb; 85(2):99-104. PubMed ID: 16498538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.